Checkpoint inhibitors fire up different types of T cells to attack tumors

Checkpoint inhibitors fire up different types of T cells to attack tumors

For Immediate Release – August 10, 2017 Anti-CTLA-4 and anti-PD-1 immunotherapies expand distinct immune infiltrates against cancer HOUSTON — Cancer immunotherapies that block two different checkpoints on T cells launch immune attacks on cancer by expanding distinct types of T cell that infiltrate tumors, researchers from The University of Texas MD Anderson Cancer Center report in the journal Cell. “The mechanisms these two therapies use mostly do not overlap, which provides a reason why combining […]